AxoGen, Inc. Appoints Christopher Crisman as Vice President, U.S. Sales
January 07, 2019 at 07:30 pm IST
Share
AxoGen, Inc. announced the appointment of Christopher Crisman as Vice President, U.S. Sales, effective immediately. He brings nearly thirty years of medical device sales execution expertise to AxoGen, having successfully built and led several large, productive sales organizations. During his career Crisman launched multiple new products and clinical procedures, expanded and optimized sales and marketing organizations, and motivated teams to achieve high performance results. Crisman has held leadership positions across sales, marketing, and corporate accounts for several large medical device companies. He served as a Divisional/Zone Vice President for sales at Boston Scientific Corporation, leading the cardiac rhythm management field sales and clinical support teams as well as the interventional cardiology and corporate sales teams in the Southeast. Mr. Crisman’s employment will begin on January 7, 2019 on the terms of that certain employment agreement by and between Mr. Crisman and the Company dated as of January 7, 2019.
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
AXOGEN, INC. 
